Search Results - "Fogel, Ronald P"

Plecanatide Is Effective and Safe in the Treatment for Chronic Idiopathic Constipation: Results of a Phase II Trial by Barish, Charles, Dorn, Spencer, Fogel, Ronald P., Patel, Reema, Rosenberg, Jonathan

“…Background Many patients with chronic idiopathic constipation (CIC) remain unsatisfied with their treatment options. Plecanatide is a pH-sensitive uroguanylin…”
Get full text

Long‐term safety of tenapanor in patients with irritable bowel syndrome with constipation in the T3MPO ‐3 study by Lembo, Anthony J., Friedenberg, Keith A., Fogel, Ronald P., Edelstein, Susan, Zhao, Suling, Yang, Yang, Rosenbaum, David P., Chey, William D.

“…BackgroundTenapanor, a first‐in‐class, minimally systemic inhibitor of intestinal sodium/hydrogen exchanger isoform 3 (NHE3), is approved for the treatment of…”
Get full text

Plecanatide Improves Symptoms of Irritable Bowel Syndrome with Constipation: Results of an Integrated Efficacy and Safety Analysis of Two Phase 3 Trials by Brenner, Darren M, Dorn, Spencer D, Fogel, Ronald P, Christie, Jennifer, Laitman, Adam P, Rosenberg, Jonathan

“…Purpose: Patients with irritable bowel syndrome with constipation (IBS-C) experience abdominal pain with altered bowel movements. Plecanatide is indicated as…”
Get full text

Tu1375: TENAPANOR HAS EARLY ONSET OF ACTION IN TREATING SYMPTOMS OF IRRITABLE BOWEL SYNDROME WITH CONSTIPATION (IBS-C) (T3MPO-1 AND T3MPO-2 TRIALS) by Fogel, Ronald P., Edelstein, Susan, Yang, Yang, Rosenbaum, David P.

Get full text

Tu1375: TENAPANOR HAS EARLY ONSET OF ACTION IN TREATING SYMPTOMS OF IRRITABLE BOWEL SYNDROME WITH CONSTIPATION (IBS-C) (T3MPO-1 AND T3MPO-2 TRIALS) by Fogel, Ronald P., Edelstein, Susan, Yang, Yang, Rosenbaum, David P.

Get full text

535: EFFICACY AND SAFETY OF VIBRANT® CAPSULE FOR CHRONIC IDIOPATHIC CONSTIPATION (CIC): RANDOMIZED, DOUBLE-BLIND, MULTICENTER, PLACEBO-CONTROLLED, PHASE III TRIAL by Rao, Satish S., Quigley, Eamonn, Chey, William D., Sharma, Amol, Dinh, Dinh V., Dunn, Leonard, Fogel, Ronald P., Romero, Sandor, Teltser, Matthew, Morin, Robert, Torres, Louis, Surowitz, Ronald, Reddy, Vishnu, Wayne, Jeffrey D., Snook, Murray, Goldstein, Gary, Rubino, John, Freeman, George, Lumicao, Benjamin, Greenwald, James, Zopo, Alex, Wild, James, Hellstern, Paul, Murray, Alexander, Usdan, Lisa, Whitmer, Daniel, Oza, Amita, Friedenberg, Keith, Lembo, Anthony

Get full text

Fr531 EFFICACY AND SAFETY OF FILGOTINIB AS MAINTENANCE THERAPY FOR PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS: RESULTS FROM THE PHASE 2B/3 SELECTION STUDY by Peyrin-Biroulet, Laurent, Loftus, Edward V., Danese, Silvio, Vermeire, Séverine, Sandborn, William J., Fogel, Ronald P., Nijhawan, Sandeep, Kempinski, Radoslaw, Filip, Rafal, Hospodarskyy, Ihor, McNally, John, Yun, Chohee, Zhao, Sally, Liu, Xiaopeng, Tasset, Chantal T., Besuyen, Robin, Watanabe, Mamoru, Schreiber, Stefan, Rogler, Gerhard, Hibi, Toshifumi, Feagan, Brian G.

Get full text

813 - Apremilast for Active Ulcerative Colitis: A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study by Danese, Silvio, Neurath, Markus, Kopon, Adam, Zakko, Salam F., Simmons, Timothy C., Fogel, Ronald P., Maccarone, Judy, Zhan, Xiaojiang, Usiskin, Keith, Chitkara, Denesh

Get full text

Stress ulcer prophylaxis in medical ICU patients: annual utilization in relation to the incidence of endoscopically proven stress ulceration by Devlin, JW, Ben-Menachem, T, Ulep, SK, Peters, MJ, Fogel, RP, Zarowitz, BJ

“…OBJECTIVE: To measure changes in the proportion of medical intensive care unit (MICU) patients prescribed pharmacologic stress ulcer prophylaxis therapy over a…”
Get full text

Efficacy and safety of gluten peptide-based antigen-specific immunotherapy (Nexvax2) in adults with coeliac disease after bolus exposure to gluten (RESET CeD): an interim analysis of a terminated randomised, double-blind, placebo-controlled phase 2 study by Tye-Din, Jason A, Daveson, A James M, Goel, Gautam, Goldstein, Kaela E, Hand, Holly L, Neff, Kristin M, Popp, Alina, Taavela, Juha, Maki, Markku, Isola, Jorma, Williams, Leslie J, Truitt, Kenneth E, Anderson, Robert P

“…A gluten-free diet is insufficient to treat coeliac disease because intestinal injury persists and acute reactions with cytokine release follow gluten…”
Get more information

Surgery for Crohn’s Disease Is Associated With a Dysbiotic Microbiome and Metabolome: Results From Two Prospective Cohorts by Lewis, James D., Daniel, Scott G., Li, Hongzhe, Hao, Fuhua, Patterson, Andrew D., Hecht, Aaron L., Brensinger, Colleen M., Wu, Gary D., Bittinger, Kyle, Wolf, Douglas C., Hron, Bridget, Hanson, John S., Mohanty, Sanjib P., Fogel, Ronald P., Levy, L. Campbell, Iskandar, Heba N., Fischer, Monika, Cohen, Benjamin, Swaminath, Arun, Kane, Sunanda, McCabe, Robert P., Yen, Eugene F., Hanauer, Stephen B., Hudesman, David P., Afzali, Anita, Kelly, Colleen, Weber, John R., Mahadevan, Uma, Herfarth, Hans, Katz, Jeffery, Taleban, Sasha, Rubin, David T., Yachyshyn, Bruce, Reynolds, Gorman J., Gerich, Mark, Dryden, Gerald W., Quezada, Sandra, Higgins, Peter D.R., Shmidt, Eugenia, Lewis, James D., Schwartz, Marc B., Flynn, Ann D., Saha, Sumona, Horst, Sara N., Chiorean, Michael, Green, Patrick D., Scherl, Ellen J., Sandler, Robert, Brotherton, Carol, Albenberg, Lindsey, Valentine, John F., Suskind, David, Meyer, Andrea, Compher, Charlene W., Bewtra, Meenakshi, Hanson, John S., Kaur, Manreet, Dassopoulos, Themistocles, Snapper, Scott B., Korzenik, Joshua R., Bohm, Matthew, Raffals, Laura, Beniwal-Patel, Poonam, Hudesman, David, Russ, Kirk, Brook, Loren, Pekow, Joel, Cross, Raymond, Wong, Uni, Bishu, Shrinivas, Bewtra, Meenakshi, Lewis, James D., Duerr, Richard, Saha, Sumona, Caldera, Freddy, Scoville, Elizabeth, Deepak, Parakkal, Ciorba, Matthew

“…Crohn’s disease is associated with alterations in the gut microbiome and metabolome described as dysbiosis. We characterized the microbial and metabolic…”
Get full text

Safety and Efficacy of Mitemcinal Furnarate (GM-611) in Diabetic Gastroparesis: 12-Week, Multi-Center, Double-Blind, Placebo-Contolled, Phase 2b Study (GM-611-05) by Faichney, John D, Goldstein, Barry J, Fogel, Ronald P, McCallum, Richard W

Get full text

Liquid caustic ingestion. Spectrum of injury by Cello, J P, Fogel, R P, Boland, C R

“…Seventeen patients who ingested liquid caustics were reviewed for location, extent, severity, and outcome of the mucosal injury. Although many complained of…”
Get more information